GHISO, ELENA
GHISO, ELENA
ONCOLOGIA
Activation of HER family members in gastric carcinoma cells mediates resistance to MET inhibition.
2010-01-01 S. Corso;E. Ghiso;V. Cepero;J. R. Sierra;C. Migliore;A. Bertotti;L. Trusolino;P. M. Comoglio;S. Giordano
Expression of c-jun is not mandatory for mouse hepatocyte proliferation induced by two nuclear receptor ligands: TCPOBOP and T3
2011-01-01 Leoni VP;Ledda-Columbano GM;Pibiri M;Saliba C;Perra A;Kowalik MA;Grober OM;Ravo M;Weisz A;Locker J;Ghiso E;Giordano S;Columbano A
MET and KRAS gene amplification mediates acquired resistance to MET tyrosine kinase inhibitors.
2010-01-01 V. Cepero;J. R. Sierra;S. Corso;E. Ghiso;L. Casorzo;T. Perera;P. M. Comoglio;S. Giordano
MicroRNAs impair MET-mediated invasive growth
2008-01-01 Cristina Migliore; Annalisa Petrelli; Elena Ghiso; Simona Corso; Lorena Capparuccia; Adriana Eramo; Paolo M.Comoglio; Silvia Giordano
miR-205 mediates adaptive resistance to MET inhibition via ERRFI1 targeting and raised EGFR signaling
2018-01-01 Migliore, Cristina; Morando, Elena; Ghiso, Elena; Anastasi, Sergio; Leoni, Vera P; Apicella, Maria; Cora', Davide; Sapino, Anna; Pietrantonio, Filippo; De Braud, Filippo; Columbano, Amedeo; Segatto, Oreste; Giordano, Silvia
Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression.
2012-01-01 Petrelli A;Perra A;Schernhuber K;Cargnelutti M;Salvi A;Migliore C;Ghiso E;Benetti A;Barlati S;Ledda-Columbano GM;Portolani N;De Petro G;Columbano A;Giordano S
Silencing the MET oncogene leads to regression of experimental tumors and metastases
2008-01-01 CORSO S; MIGLIORE C; GHISO E; DE ROSA G; COMOGLIO P; GIORDANO S
Targeting MET: why, where and how?
2013-01-01 Ghiso E;Giordano S
YAP activation is an early event and a potential therapeutic target in liver cancer development.
2014-01-01 Perra A;Kowalik MA;Ghiso E;Ledda-Columbano GM;Di Tommaso L;Angioni MM;Raschioni C;Testore E;Roncalli M;Giordano S;Columbano A
YAP-Dependent AXL Overexpression Mediates Resistance to EGFR Inhibitors in NSCLC
2017-01-01 Ghiso, Elena*; Migliore, Cristina; Ciciriello, Vito; Morando, Elena; Petrelli, Annalisa; Corso, Simona; De Luca, Emmanuele; Gatti, Gaia; Volante, Marco; Giordano, Silvia
Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice.
2011-01-01 Kowalik MA;Saliba C;Pibiri M;Perra A;Ledda-Columbano GM;Sarotto I;Ghiso E;Giordano S;Columbano A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Activation of HER family members in gastric carcinoma cells mediates resistance to MET inhibition. | 2010 | S. Corso;E. Ghiso;V. Cepero;J. R. Sierra;C. Migliore;A. Bertotti;L. Trusolino;P. M. Comoglio;S. Giordano | |
| Expression of c-jun is not mandatory for mouse hepatocyte proliferation induced by two nuclear receptor ligands: TCPOBOP and T3 | 2011 | Leoni VP;Ledda-Columbano GM;Pibiri M;Saliba C;Perra A;Kowalik MA;Grober OM;Ravo M;Weisz A;Locker J;Ghiso E;Giordano S;Columbano A | |
| MET and KRAS gene amplification mediates acquired resistance to MET tyrosine kinase inhibitors. | 2010 | V. Cepero;J. R. Sierra;S. Corso;E. Ghiso;L. Casorzo;T. Perera;P. M. Comoglio;S. Giordano | |
| MicroRNAs impair MET-mediated invasive growth | 2008 | Cristina Migliore; Annalisa Petrelli; Elena Ghiso; Simona Corso; Lorena Capparuccia; Adriana Eramo; Paolo M.Comoglio; Silvia Giordano | |
| miR-205 mediates adaptive resistance to MET inhibition via ERRFI1 targeting and raised EGFR signaling | 2018 | Migliore, Cristina; Morando, Elena; Ghiso, Elena; Anastasi, Sergio; Leoni, Vera P; Apicella, Maria; Cora', Davide; Sapino, Anna; Pietrantonio, Filippo; De Braud, Filippo; Columbano, Amedeo; Segatto, Oreste; Giordano, Silvia | |
| Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression. | 2012 | Petrelli A;Perra A;Schernhuber K;Cargnelutti M;Salvi A;Migliore C;Ghiso E;Benetti A;Barlati S;Ledda-Columbano GM;Portolani N;De Petro G;Columbano A;Giordano S | |
| Silencing the MET oncogene leads to regression of experimental tumors and metastases | 2008 | CORSO S; MIGLIORE C; GHISO E; DE ROSA G; COMOGLIO P; GIORDANO S | |
| Targeting MET: why, where and how? | 2013 | Ghiso E;Giordano S | |
| YAP activation is an early event and a potential therapeutic target in liver cancer development. | 2014 | Perra A;Kowalik MA;Ghiso E;Ledda-Columbano GM;Di Tommaso L;Angioni MM;Raschioni C;Testore E;Roncalli M;Giordano S;Columbano A | |
| YAP-Dependent AXL Overexpression Mediates Resistance to EGFR Inhibitors in NSCLC | 2017 | Ghiso, Elena*; Migliore, Cristina; Ciciriello, Vito; Morando, Elena; Petrelli, Annalisa; Corso, Simona; De Luca, Emmanuele; Gatti, Gaia; Volante, Marco; Giordano, Silvia | |
| Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice. | 2011 | Kowalik MA;Saliba C;Pibiri M;Perra A;Ledda-Columbano GM;Sarotto I;Ghiso E;Giordano S;Columbano A |